Hydromorphone Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Hydromorphone Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Nov 3, 2017.

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-0121-25
Dosage Form
Injection
Presentation
Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)
Initial Posting
Nov 3, 2017

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.